References

1. Mahale NB, Thakkar PD, Mali RG, Walunj DR, Chaudhari SR (2012) Niosomes: Novel sustained release nonionic stable vesicular systems - An overview. Adv Colloid Interface Sci 183-184: 46-54. View
2. Sankhyan A, Pawar P (2012) Recent Trends in Niosome as Vesicular Drug Delivery System. Journal of Applied Pharmaceutical Science 06: 20-32. View
3. Arunothayanun P, Turton JA, Uchegbu IF, Florence AT (1999) Preparation and in vitro in vivo evaluation of luteinizing hormone releasing hormone (LHRH)-loaded polyhedral and spherical tubular niosomes. J Pharm Sci 88: 34-38. View
4. Uchegbu IF, Double JA, Turton JA, Florence AT (1995) Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse. Pharm Res 12: 1019- 1024. View
5. Tarekegn A , Joseph MN, Palani S, Zacharia A , Ayenew Z (2010) Niosomes in targeted drug delivery: Some recent advances. International Journal of Pharmaceutical Sciences and Research 9: 1-8. View
6. Schreier H, Bouwstra J (1994) Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Rel 30: 1-15. View
7. Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, et al. (2009) Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 377: 1-8. View
8. Hao Y, Zhao F, Li N, Yang Y, Li K (2002) Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 244: 73-80. View
9. Fang JY, Yu SY, Wu PC, Huang YB, Tsai YH (2001) In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215: 91-99. View
10. Nasir A, Harikumar SL, Amanpreet K (2012) Niosomes: An excellent tool for drug delivery. International Journal of Research In Pharmacy and Chemistry 2: 479- 487. View
11. Vyas SP, Khar RK (2011) Targeted and Controlled Drug Delivery: Novel Carrier Systems. CBS Publishers and Distributors, New Delhi 249 - 279. View
12. Khan A, Sharma P K, Visht S, Malviya R (2011) Niosomes as colloidal drug delivery system: A review. J Chronotherapy Drug Del 2: 15-21.
13. Srinivas S, Anand K Y, Hemanth A. Anitha M (2010) Preparation and evaluation of niosomes containing aceclofenac. Digest Journal of Nanomaterials and Biostructures 1: 249 - 254.
14. Dingelf JT, Parker M (1997) NSAID stimulation of human cartilage matrix synthesis. Clin drug invest 14: 353-362. View
15. Akimotoa H, Yamazakib R, Hashimotob S, Satoa T, Ito A (2000) 4′-Hydroxy aceclofenac suppresses the interleukin-1-induced production of promatrix metalloproteinases and release of sulfated-glycosaminoglycans from rabbit articular chondrocytes. Eur J pharmacol 401: 429-436. View
16. Tank CJ, Borkhataria CH, Baria AH, Patel RP, Tamizharasi SS, et al. (2009) Formulation and Evaluation of Aceclofenac loaded Maltdextrin based Proniosome. Int J ChemTech Res 1: 567-573. View
17. Medicines Compendium (2003) Published by Data Pharm Communication Britain 1724.
18. Szoka F Jr, Papahadjopoulos D (1978) Procedure for preparation of liposomes with large internal aqueous space and high capture by reversephase evaporation. Proc Natl Acad Sci USA 75: 4194-4198. View
19. Guinedi AS, Mortada ND, Mansour S, Hathout RM (2005) Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306: 71-82. View
20. Aggarwal D, Kaur IP (2005) Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm 290: 155-159. View
21. Hu C, Rhodes DG (1999) Proniosomes: a novel drug carrier preparation. Int J Pharm 185: 23-35. View
22. Schmolka IR (1972) Artificial skin I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 6: 571-582. View
23. Speroni E, Schwaiger S, Egger P, Berger AT, Cervellati R, et al. (2006) In vivo efficacy of different extracts of Edelweiss (Leontopodium alpinum Cass.) in animal models. J Ethnopharmacol 105: 421-426. View
24. Chi SC, Jun HW (1990) Anti-inflammatory activity of ketoprofen gel on carrageenan-induced paw edema in rats. J Pharm Sci 79: 974- 977. View
25. Rojanapanthu P, Sarisuta N, Chaturon K, Kraisintu K (2003) Physicochemical properties of amphotericin B liposomes prepared by reverse-phase evaporation method. Drug Dev Ind Pharm 1: 31-37. View
26. Deniz A, Sade A, Severcan F, Keskin D, Tezcaner A, et al. (2010) Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics. Biosci Rep 30: 365-373. View
27. Bernsdorff C, Wolf A, Winter R, Gratton E (1997) Effect of hydrostatic pressure on water penetration and rotational dynamics in phospholipidcholesterol bilayers. Biophys J 3:1264-1277. View
28. Kirby C, Clarke J, Gregoriadis G (1980) Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 2: 591-598. View
29. Lingan M A, Sathalim A H, Kumar R V, Gokila A (2011) Formulation and evaluation of topical delivery system containing Clobetasol propionate niosomes. Sci Revs Chem Commun 1: 7-17.
30. Agarwal S, Vasudha B, Villa P, Raghuram AP, Pandey S, et al. (2004) Effect of cholesterol content and surfactant HLB on vesicle properties of niosomes. Indian J Pharm Sci 1:121-123. View
31. Mokhtar M, Sammour OA, Hammad MA, Megrab NA (2008) Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361: 104-111. View
32. Singh CH, Jain CP, Kumar BN (2011) Formulation, characterization, stability and in vitro evaluation of Nimesulide niosomes. Pharmacophore 3: 168-185. View
33. Dehghan MH, Hussain MA (2010) Development and evaluation of niosomal delivery system for Aceclofenac. Int J Pharm & Tech 4: 1028-1045. View
34. Gupta PK, Hung CT Perrier DG (1987) Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysis. J Pharm Sci 33:141-145. View
35. Sheena IP, Singh UV, Kamath R, Uma Devi P, Udupa N (1998) Niosomal withaferin A, with better antitumor efficacy. Indian J Pharm Sci 2: 45-48. View
36. El- Ridy MS, Badawi AA, Safar MM, Mohsen AM (2012) Niosomes as a novel pharmaceutical formulation encapsulating the hepatoprotective drug Silymarin. Int J Pharm Pharm Sci 1: 549-559. View
37. Begum MY, Abbulu K, Sudhakar M (2012) Preparation, characterization and in-vitro release study of flurbiprofen loaded stealth liposomes. Chem Sci Trans 1: 201-209. View
38. Nagarsenker MS, Londhe VY, Nadkarni GD (1999) Preparation and evaluation of liposomal formulations of tropicamid for ocular delivery. Int J Pharm 190: 63-71. View
39. Hathout RM, Mansour S, Mortada ND, Guinedi AS (2007) Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 1: 1-12. View
40. Barakat HS, Darwish IA, El-Khordagui LK, Khalafallah NM (2009) Development of naftifine hydrochloride alcohol-free niosome gel. Drug Dev Ind Pharm 5: 631-637. View
41. Doxastakis M, Sum AK, de Pablo JJ (2005) Modulating membrane properties: the effect of trehalose and cholesterol on a phospholipid bilayer. J Phys Chem B 50: 24173-24181. View
42. Jadon, PS, Gajbhiye V, Jadon RS, Gajbhiye KR, Ganesh N (2009) Enhanced Oral Bioavailability of Griseofulvin via Niosomes. AAPS PharmSciTech 4: 1186-1192. View
43. El-badry M, Fetih G (2011) Preparation, characterization and antiinflammatory activity of celecoxib chitosan gel formulations. J Drug Del Sci Tech 21: 201-206. View
44. Fetih G (2010) Meloxicam formulations for transdermal delivery: hydrogels versus organogels. J Drug Del Sci Tech 20: 451-456. View
45. Reddy DN, Udupa N (1993) Formulation and evaluation of oral and transdermal preparations of flurbiprofen and piroxicam incorporated with different carriers. Drug Dev Ind Pharm 7: 843-852. View
46. Junginger HE, Hofland HEJ, Bouwstra JA (1991) Liposomes and niosomes: interactions with human skin. Cosmetics and toiletries 8: 45-50.
47. Uchegbu IF, Vyas SP (1998) Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1-2: 33-70. View
48. Barry BW (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2:101-114. View
49. Ogiso T, Niinaka N, Iwaki M (1996) Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. J Pharm Sci 1: 57-64. View